888腾博会
EN
EN
中文
请输入要搜索的内容
Home
About Us
Who We Are
Management Team
Culture
Awards
Product Center
Healthcare
Bone Health
Medical Nutrition
Functional Skincare
Prescription Drugs
Gastroenterology
Critical Care
Metabolic Diseases
Innovative Drugs
Liver Disease
Oncology
Rare Diseases
Innovative Medical Devices
AI Radiosurgery Robot
Artificial Heart
Atrial Fibrillation
Innovation Layout
Production Operation
News
Investor Relations
Stock Data
Information Disclosure
Investor Interaction
General Meeting of Shareholders Vote
Sustainable Development
ESG Report
Social Responsibility Sustainability
Brand Citizenship??
Career
Talent Philosophy
Talent Development
Compensation and Benefits
一级标题
一级标题
News
our news
News
-
our news
Baheal Medical and Shanghai Yizhong Jointly Explore the Commercialization of Innovative Anti-tumor Drugs
2022-05-31
Baheal Medical was Selected as 2021 Top 50 Service Enterprises in Shandong
2021-12-01
Baheal Medical was again Selected to the Qingdao Golden Flower List as a New Generation Cultivated Enterprise
2021-12-14
Baheal Medical’s Collaboration with Astellas China Again to Promote Commercialization of Therapeutic Drugs in the Urology Field
2021-11-09
Baheal Medical Lands on ChiNext Board Today!
2021-07-01
Baheal Medical Launches Commercialization Platform of Efficacious Cosmetics
2021-05-13
«
1
2
3
4
5
6
»
Home
About Us
Product Center
Production Platform
Investor Relations
News
Sustainable Development
Join Us
86-532-67773303
Copyright © 2022 baheal.cn, All Rights Reserved
鲁ICP备10008593号-9
互联网药品信息服务资格证 证书编号：(鲁)-经营性-2021-0233
Privacy
Legal provisions
Contact us
Qingdao Baheal Medical INC.
Back to top
返回顶部
【网站地图】
